PKBSM0561GQKP

human beta cell line

EndoC-bH3 cells treated with 4-hydroxy tamoxifen for three weeks from GSE207816

DMEM low glucose (1 g/L) supplemented with 2% fatty acid free BSA , 10 mM nicotinamide, 5.5 µg/mL human transferrin, 6.7 ng/mL sodium selenite, 50 µM β-mercaptoethanol, 100 U/mL penicillin and 100 µg/mL streptomycin

EndoC-bH3

released

EndoC-bH3 cell line, treated with 1 mM 4-hydroxy tamoxifen for 21 days

Homo sapiens